Nigella sativa stimulates insulin secretion from isolated rat islets and inhibits the digestion and absorption of (CH2O)n in the gut
Open Access
- 23 August 2019
- journal article
- research article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 39 (8)
Abstract
Nigella sativa seeds are traditionally reputed as possessing anti-diabetic properties. As a result, we aim to explore the mechanism of its anti-hyperglycemic activity. The present study uses various experimental designs including gastrointestinal (GI) motility, intestinal disaccharidase activity and inhibition of carbohydrate digestion and absorption in the gut. The animals used as type 2 diabetic models were induced with streptozotocin to make them as such. Oral glucose tolerance test was performed to confirm that the animals were indeed diabetic. The extract reduced postprandial glucose, suggesting it interfered with glucose absorption in the gut. It also improved glucose (2.5g/kg, b/w) tolerance in rats. Furthermore, treatment with N. sativa produced a significant improvement in GI motility, while reduced disaccharidase enzyme activity in fasted rats. The extract produced a similar effect within an acute oral sucrose (2.5g/kg, b/w) load assay. Following sucrose administration, a substantial amount of unabsorbed sucrose was found in six different parts of the GI tract. This indicates that N. sativa has the potentiality to liberate GI content and reduce or delay glucose absorption. A potential hypoglycemic activity of the extract found in insulin release assay, where the extract significantly improved insulin secretion from isolated rat islets. These concluded present findings give rise to the implication that N. sativa seeds are generating postprandial anti-hyperglycemic activity within type 2 diabetic animal models via reducing or delaying carbohydrate digestion and absorption in the gut as well as improving insulin secretion in response to the plasma glucose.Keywords
This publication has 45 references indexed in Scilit:
- RETRACTED ARTICLE: Protective and antidiabetic effects of extract from Nigella sativa on blood glucose concentrations against streptozotocin (STZ)-induced diabetic in rats: an experimental study with histopathological evaluationDiagnostic Pathology, 2013
- A review on therapeutic potential of Nigella sativa: A miracle herbAsian Pacific Journal of Tropical Biomedicine, 2013
- Maternal supplementation of diabetic mice with thymoquinone protects their offspring from abnormal obesity and diabetes by modulating their lipid profile and free radical production and restoring lymphocyte proliferation via PI3K/AKT signalingLipids in Health and Disease, 2013
- Ameliorating effects of two extracts of Nigella sativa in middle cerebral artery occluded ratJournal of Pharmacy and Bioallied Sciences, 2012
- DETECTION OF THE ANTIBACTERIAL EFFECT OF NIGELLA SATIVA GROUND SEEDSWITH WATERAfrican Journal of Traditional, Complementary and Alternative Medicines, 2011
- Effects of Nigella sativa and thymoquinone on biochemical and subcellular changes in pancreatic β‐cells of streptozotocin‐induced diabetic ratsJournal of Diabetes, 2010
- The mechanisms of alloxan- and streptozotocin-induced diabetesDiabetologia, 2007
- Insulin secretory actions of extracts of Asparagus racemosus root in perfused pancreas, isolated islets and clonal pancreatic β-cellsJournal of Endocrinology, 2007
- Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)The Lancet, 1998
- Is hyperglycemia associated with cardiovascular disease? The Framingham StudyAmerican Heart Journal, 1991